New Cancer Drug Function Added to Criticized Cosmic System

Sweden’s Cosmic electronic health records system is undergoing a significant overhaul with the introduction of a new function for ordering and prescribing cytostatic drugs. This change, prompted by previous concerns about dosage calculations, has ignited apprehension among healthcare professionals regarding potential errors and the system’s dependability. The move is already facing criticism, with the CEO of Cambios, Rami Avidan, now addressing the issues publicly.

The core of the controversy lies in the complexity of the Cosmic system, particularly its journal functionality, which has been criticized across nine Swedish regions for being overly intricate and difficult to navigate. This new addition to the system, intended to streamline the prescription of chemotherapy drugs, is exacerbating these existing issues. Healthcare professionals fear that the integration will introduce new vulnerabilities for dosage errors, potentially jeopardizing patient safety. Rami Avidan’s interview with Dagens Nyheter marks the first time Cambios, the company behind Cosmic, is directly responding to these widespread criticisms, suggesting a potential shift in their approach to system development and implementation.

Summarized from the sources above. Read the originals for the full story.